Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10:1–11.
Moheb M, Iraji A, Dastyafteh N, Khalili Ghomi M, Noori M, Mojtabavi S, et al. Synthesis and bioactivities evaluation of quinazolin-4 (3 H)-one derivatives as α-glucosidase inhibitors. BMC Chem. 2022;16:97.
Article CAS PubMed PubMed Central Google Scholar
DiNicolantonio JJ, Bhutani J, O’Keefe JH. Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes. Open heart. 2015;2:e000327.
Article PubMed PubMed Central Google Scholar
Avery MA, Mizuno CS, Chittiboyina AG, Kurtz TW, Pershadsingh HA. Type 2 diabetes and oral antihyperglycemic drugs. Curr Med Chem. 2008;15:61–74.
Tundis R, Loizzo MR, Menichini F. Natural products as α-amylase and α-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update. Mini-Rev Med Chem. 2010;10:315–31.
Article CAS PubMed Google Scholar
Lebovitz HE. A new oral therapy for diabetes management: alpha-glucosidase inhibition with acarbose. Clinical diabetes. 1995;13:99–104.
Noori M, Davoodi A, Iraji A, Dastyafteh N, Khalili M, Asadi M, et al. Design, synthesis, and in silico studies of quinoline-based-benzo [d] imidazole bearing different acetamide derivatives as potent α-glucosidase inhibitors. Sci Rep. 2022;12:14019.
Article CAS PubMed PubMed Central Google Scholar
Adib M, Peytam F, Rahmanian-Jazi M, Mohammadi-Khanaposhtani M, Mahernia S, Bijanzadeh HR, et al. Design, synthesis and in vitro α-glucosidase inhibition of novel coumarin-pyridines as potent antidiabetic agents. New J Chem. 2018;42:17268–78.
Kazempour-Dizaji M, Mojtabavi S, Sadri A, Ghanbarpour A, Faramarzi MA, Navidpour L. Arylureidoaurones: Synthesis, in vitro α-glucosidase, and α-amylase inhibition activity. Bioorg Chem. 2023;139:106709.
Article CAS PubMed Google Scholar
Figueiredo-González M, Grosso C, Valentão P, Andrade PB. α-Glucosidase and α-amylase inhibitors from Myrcia spp.: a stronger alternative to acarbose? J Pharm Biomed Anal. 2016;118:322–7.
Kwon YI, Apostolidis E, Shetty K. Inhibitory potential of wine and tea against α‐amylase and α‐glucosidase for management of hyperglycemia linked to type 2 diabetes. J Food Biochem. 2008;32:15–31.
Spasov AA, Yozhitsa IN, Bugaeva LI, Anisimova VA. Benzimidazole derivatives: Spectrum of pharmacological activity and toxicological properties (a review). Pharm Chem J. 1999;33:232–43.
Keri RS, Hiremathad A, Budagumpi S, Nagaraja BM. Comprehensive review in current developments of benzimidazole‐based medicinal chemistry. Chem Biol Drug Des. 2015;86:19–65.
Wu K, Peng X, Chen M, Li Y, Tang G, Peng J, et al. Recent progress of research on anti‐tumor agents using benzimidazole as the structure unit. Chem Biol Drug Des. 2022;99:736–57.
Article CAS PubMed Google Scholar
Venugopal S, Kaur B, Verma A, Wadhwa P, Magan M, Hudda S, et al. Recent advances of benzimidazole as anticancer agents. Chem Biol Drug Des. 2023;102:357–76.
Article CAS PubMed Google Scholar
Flores-Carrillo P, Velázquez-López JM, Aguayo-Ortiz R, Hernández-Campos A, Trejo-Soto PJ, Yépez-Mulia L, et al. Synthesis, antiprotozoal activity, and chemoinformatic analysis of 2-(methylthio)-1H-benzimidazole-5-carboxamide derivatives: Identification of new selective giardicidal and trichomonicidal compounds. Eur J Med Chem. 2017;137:211–20.
Article CAS PubMed Google Scholar
Ibraheem F, Ahmad M, Ashfaq UA, Aslam S, Ali Khan Z, Sultan S. Synthesis, molecular docking and anti-diabetic studies of novel benzimidazole-pyrazoline hybrid molecules. Pak J Pharm Sci. 2020;23:847–54.
Patagar DN, Batakurki SR, Kusanur R, Patra SM, Saravanakumar S, Ghate M. Synthesis, antioxidant and anti-diabetic potential of novel benzimidazole substituted coumarin-3-carboxamides. J Mol Struct. 2023;1274:134589.
Spasov AA, Vassiliev PM, Anisimova VA, Zhukovskaya ON Antidiabetogenic features of benzimidazoles. Chemistry and Applications of Benzimidazole and its Derivatives: IntechOpen. 2019;73–87.
Taha M, Rahim F, Adalath B, Imran S, Khan KM, Uddin N, et al. Synthesis of benzimidazole derivatives and their antiglycation, antioxidant, antiurease and molecular docking study. Arab J Chem. 2024;17:105700.
Karimian S, Shekouhy M, Pirhadi S, Iraji A, Attarroshan M, Edraki N, et al. Synthesis and biological evaluation of benzimidazoles/1, 3, 5-triazine-2, 4-diamine hybrid compounds: a new class of multifunctional alzheimer targeting agents. New J Chem. 2022;46:15567–84.
Faydalı N, Arpacı ÖT. Benzimidazole and Benzoxazole Derivatives Against Alzheimer’s Disease. Chem Biodivers. 2024;21:e202400123.
Machhi J, Prajapati N, Kanhed AM, Patel K, Giridhar R, Yadav MR. D3 Antagonist and Antipsychotic Potential of Some Novel Benzazepines. J Pharm Sci Pharmacol. 2015;2:123–33.
Iqbal H, Yadav P, Verma AK, Mishra D, Vamadevan B, Singh D, et al. Anti-inflammatory, anti-oxidant and cardio-protective properties of novel fluorophenyl benzimidazole in L-NAME-induced hypertensive rats. Eur J Pharmacol. 2022;929:175132.
Article CAS PubMed Google Scholar
Bhandari SV, Nagras OG, Kuthe PV, Sarkate AP, Waghamare KS, Pansare DN, et al. Design, synthesis, molecular docking and antioxidant evaluation of benzimidazole-1, 3, 4 oxadiazole derivatives. J Mol Struct. 2023;1276:134747.
Singh N, Pandurangan A, Rana K, Anand P, Ahamad A, Tiwari AK. Benzimidazole: A short review of their antimicrobial activities. Int Current Pharm J. 2012;1:119–27.
Mao L, Wang S, Qu Y, Wang H, Zhao Y, Zhu C, et al. Design, synthesis, and anti-respiratory syncytial virus potential of novel 3-(1, 2, 3-triazol-1-yl) furoxazine-fused benzimidazole derivatives. Eur J Med Chem. 2023;261:115799.
Article CAS PubMed Google Scholar
Asgari MS, Mohammadi-Khanaposhtani M, Kiani M, Ranjbar PR, Zabihi E, Pourbagher R, et al. Biscoumarin-1, 2, 3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies. Bioorg Chem. 2019;92:103206.
Article CAS PubMed Google Scholar
Kumar L, Lal K, Yadav P, Kumar A, Paul AK. Synthesis, characterization, α-glucosidase inhibition and molecular modeling studies of some pyrazoline-1H-1, 2, 3-triazole hybrids. J Mol Struct. 2020;1216:128253.
Jabeen F, Shehzadi SA, Fatmi MQ, Shaheen S, Iqbal L, Afza N, et al. Synthesis, in vitro and computational studies of 1, 4-disubstituted 1, 2, 3-triazoles as potential α-glucosidase inhibitors. Bioorg Med Chem Lett. 2016;26:1029–38.
Article CAS PubMed Google Scholar
Avula SK, Khan A, Halim SA, Al-Abri Z, Anwar MU, Al-Rawahi A, et al. Synthesis of novel (R)-4-fluorophenyl-1H-1, 2, 3-triazoles: A new class of α-glucosidase inhibitors. Bioorg Chem. 2019;91:103182.
Aroua LM, Almuhaylan HR, Alminderej FM, Messaoudi S, Chigurupati S, Al-Mahmoud S, et al. A facile approach synthesis of benzoylaryl benzimidazole as potential α-amylase and α-glucosidase inhibitor with antioxidant activity. Bioorg Chem. 2021;114:105073.
Article CAS PubMed Google Scholar
Shayegan N, Iraji A, Bakhshi N, Moazzam A, Faramarzi MA, Mojtabavi S, et al. Design, synthesis, and in silico studies of benzimidazole bearing phenoxyacetamide derivatives as α-glucosidase and α-amylase inhibitors. J Mol Struct. 2022;1268:133650.
Azizian H, Pedrood K, Moazzam A, Valizadeh Y, Khavaninzadeh K, Zamani A, et al. Docking study, molecular dynamic, synthesis, anti-α-glucosidase assessment, and ADMET prediction of new benzimidazole-Schiff base derivatives. Sci Rep. 2022;12:14870.
留言 (0)